Author Correction: Prospective de novo drug design with deep interactome learning

• Kenneth Atz,
• Leandro Cotos,
• Clemens Isert,
• Maria Håkansson,
• Dorota Focht,
• Mattis Hilleke,
• David F. Nippa,
• Michael Iff,
• Jann Ledergerber,
• Carl C. G. Schiebroek,
• Valentina Romeo,
• Jan A. Hiss,
• Daniel Merk,
• Petra Schneider,
• Bernd Kuhn,
• Uwe Grether,
• Gisbert Schneider

Affiliations

Kenneth Atz

ETH Zurich, Department of Chemistry and Applied Biosciences

Leandro Cotos

ETH Zurich, Department of Chemistry and Applied Biosciences

Clemens Isert

ETH Zurich, Department of Chemistry and Applied Biosciences

Maria Håkansson

SARomics Biostructures AB

Dorota Focht

SARomics Biostructures AB

Mattis Hilleke

ETH Zurich, Department of Chemistry and Applied Biosciences

David F. Nippa

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd.

Michael Iff

ETH Zurich, Department of Chemistry and Applied Biosciences

Jann Ledergerber

ETH Zurich, Department of Chemistry and Applied Biosciences

Carl C. G. Schiebroek

ETH Zurich, Department of Chemistry and Applied Biosciences

Valentina Romeo

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd.

Jan A. Hiss

ETH Zurich, Department of Chemistry and Applied Biosciences

Daniel Merk

Department of Pharmacy, Ludwig-Maximilians-Universität München

Petra Schneider

ETH Zurich, Department of Chemistry and Applied Biosciences

Bernd Kuhn

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd.

Uwe Grether

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd.

Gisbert Schneider

ETH Zurich, Department of Chemistry and Applied Biosciences